FDA AI Drug Approval

By João L. Carapinha

May 9, 2025

The FDA AI Drug Approval initiative marks a significant milestone as the FDA completes its first pilot of generative AI aimed at enhancing scientific reviews. This aggressive plan to fully deploy AI technology across all FDA centers by June 30, 20...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.